Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001087294-14-000013
Filing Date
2014-03-13
Accepted
2014-03-12 17:31:26
Documents
5
Period of Report
2014-03-12
Effectiveness Date
2014-03-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2014proxystatement.htm DEF 14A 620815
2 cumberlandlogoa02.jpg GRAPHIC 12534
3 cumberlandpharmalogo.jpg GRAPHIC 37721
4 untitleda01.jpg GRAPHIC 9167
5 x.jpg GRAPHIC 2405
  Complete submission text file 0001087294-14-000013.txt   707514
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33637 | Film No.: 14688721
SIC: 2834 Pharmaceutical Preparations